跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG
Approved
STANDARD
ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 18, 2024
Approval ID
c4e8beb6a582e8cc
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
c4e8beb6a582e8cc
Drug Cima Aemps Name
ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number
89251
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2024-01-18
Dosage Form
SOLUCIÓN INYECTABLE
Dose
0,44 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
ERIBULINA MESILATO
0,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 18, 2024
Approval ID
c4e8beb6a582e8cc
Type
Standard
Back to CIMA-AEMPS Approvals
